• 11-01-2021

DeepIntent Survey Reveals That Pharmaceutical Advertising Motivates Patients to Research Treatment and Medication Options

DeepIntent surveyed 1,244 U.S. patients in August 2021 about their attitudes toward pharmaceutical ads and whether they find them relevant.

In this article, Pharmaceutical Executive Magazine shares key takeaways from the survey revealing how advertising motivates patients to research their treatment and medication options. DeepIntent’s CEO Chris Paquette also shares the opportunities healthcare marketers can act on as a result of this research.

Read more here.

More News

Article
From Data to Impact: DeepIntent and PurpleLab Accelerate Smarter Targeting
9-5-2025
Healthcare advertising works best when it’s both precise and efficient. That’s why we’re excited to announce a direct partnership with PurpleLab, bringing their high-quality...
Read More
Article
Oh Wow, There’s a Lot of Rules: Thriving in Pharma’s Unique Marketing Environment
9-3-2025
 What happens when a marketer who’s led powerful campaigns in fast-moving industries like CPG, retail, and financial services brings that experience to pharma?...
Read More
Article
We Cannot Send Them Any More Emails: Holding HCP Attention
8-20-2025
 Bill Veltre, EVP and Head of Media at Deerfield, joins healthcare advertising leader John Mangano on Deep to share sharp insights from a career spanning...
Read More